TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bio-Works Technologies AB
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
16,538
|
29,484
|
27,611 |
| Financial expenses |
6
|
2
|
15 |
| Earnings before taxes |
-24,212
|
-36,763
|
-29,867 |
| EBITDA |
-24,343
|
-37,437
|
-30,485 |
| Total assets |
34,095
|
41,746
|
61,219 |
| Current assets |
32,914
|
40,074
|
59,593 |
| Current liabilities |
5,139
|
12,170
|
15,985 |
| Equity capital |
28,955
|
29,576
|
45,234 |
| - share capital |
5,063
|
2,618
|
2,351 |
| Employees (average) |
33
|
39
|
43 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
84.9%
|
70.8%
|
73.9% |
| Turnover per employee |
501
|
756
|
642 |
| Profit as a percentage of turnover |
-146.4%
|
-124.7%
|
-108.2% |
| Return on assets (ROA) |
-71.0%
|
-88.1%
|
-48.8% |
| Current ratio |
640.5%
|
329.3%
|
372.8% |
| Return on equity (ROE) |
-83.6%
|
-124.3%
|
-66.0% |
| Change turnover |
-11,970
|
1,730
|
12,970 |
| Change turnover % |
-42%
|
6%
|
89% |
| Chg. No. of employees |
-6
|
-4
|
11 |
| Chg. No. of employees % |
-15%
|
-9%
|
34% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.